What's breaking now, across thousands of outlets.
Oyster says a tweak it's made to traditional protein degrading technology can help break down tau, which has long been a focus of Alzheimer’s drug research.
We haven't written up this one. BioPharma Dive has the full story — the link below goes straight to it.
The Hong Kong Doctors Union warned that the city’s Covid-19 booster programme is losing momentum, citing low uptake among older adults and high-risk groups and limited access to vaccines in the…
The Hong Kong Doctors Union warned that the city’s Covid-19 booster programme is losing momentum, citing low uptake among older adults and high-risk groups and limited access to vaccines in the…
Manufacturers of weight loss products are hoping that companies will offer their medication as a benefit to employees. Chronic obesity costs the German economy billions due to high absenteeism.
Oyster Therapeutics has raised $60 million to develop pills that destroy pathogenic forms of tau, a brain protein implicated in Alzheimer’s disease.
Could a coat of white paint help South Africans living in scorching shacks sleep better? Researchers are testing whether reflective roof paint can cool homes and improve people's health as climate…
